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Original Research ajog.orgOBSTETRICSOutcomes of the novel Odon Device in indicated
operative vaginal birth
Emily J. Hotton, MBChB; Erik Lenguerrand, PhD; Mary Alvarez, RM; Stephen O’Brien, PhD; Tim J. Draycott, MD;
Joanna F. Crofts, MD; on behalf of the ASSIST Study Team
BACKGROUND: No new method of assisting vaginal birth has been cases (48%). Of the 40 births, 21 (52.5%) required additional assistance: 18
introduced into clinical practice since the development of the vacuum
extractor in the 1950s. The Odon Device is a new device that employs a
circumferential air cuff over the fetal head to assist birth. In this study, the
Odon Device has been used to assist vaginal birth for standard clinical
indications.
OBJECTIVE: This study aimed to investigate the clinical impact, safety,
and acceptability of the Odon Device to women, their babies, and clinicians
and to assess the feasibility of recruiting women to an interventional
intrapartum research study.
STUDY DESIGN: This is a nonrandomized, single-arm interventional
feasibility study of the Odon Device for operative vaginal birth undertaken in
a single maternity unit: Southmead Hospital, Bristol, United Kingdom. The
Odon Device was used to assist birth in 40 women who required the birth
to be assisted for suspected fetal compromise and/or prolonged second
stage of labor. The primary clinical outcome was the proportion of births
successfully assisted with the Odon Device, and the primary feasibility
outcome was the proportion of eligible women who were approached and
who agreed to participate. Neonatal outcome data were reviewed at day 28,
and maternal outcomes were investigated up to day 90.
RESULTS: Between October 2018 and January 2019, 298 of 384
approached, eligible women (77.6%) consented to participate. Of these
women, 40 received the intervention—the use of the Odon Device. Birth
was assisted in all cephalic (occiput anterior, occiput transverse, and occiput
posterior) fetal positions, at all stations at or below the ischial spine and with
or without regional analgesia. The Odon Device was effective in 19 of 40Cite this article as: Hotton EJ, Lenguerrand E, Alvarez M,
et al. Outcomes of the novel Odon Device in indicated
operative vaginal birth. Am J Obstet Gynecol
2020;XX:x.exex.ex.
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https://doi.org/10.1016/j.ajog.2020.12.017of 40 births (45%) were completed using nonrotational forceps, 1 of 40
births (3%) required rotational forceps, and 2 of 40 births (5%) required an
emergency cesarean delivery. There was no serious maternal or neonatal
adverse event related to the use of the device, and there was no serious
adverse device effect. There were 4 devices (10%) that were ineffective
because of a manufacturing fault. Furthermore, 39 of 40 women (98%)
reported a high birth perception score. All practitioners were able to use the
device as intended, although some steps in using the device were reported
to be easier to perform (setup and deflation of air chamber) than others
(application of the device and withdrawal of the applicator).
CONCLUSION: Recruitment to an interventional study of a new device
for operative vaginal birth was feasible; 78% of eligible women were
willing to participate, often expressing an aspiration for an alternative to
forceps and vacuum. The success rate of the Odon Device was lower than
reported success rates of vacuum and forceps; however, in this study, the
device had been used to assist birth for standard clinical indications. There
was no significant maternal or neonatal safety concern associated with the
use of the device, although the number of births studied was small. Further
feasibility study to establish iterative changes to the device, technique, and
clinical indications is necessary.
Key words: assisted vaginal birth, feasibility, fetal compromise, intra-
partum research, management of second stage of labor, medical device,
nonreassuring fetal heart tracing, obstetrical forceps, prolonged second
stage of labor, safety, vacuum, ventouseIntroduction
The optimal duration of the second stage
of labor is contentious,1e4 but compli-
cations in the second stage of labor
remain a major cause of preventable
maternal and neonatal morbidities and
mortalities globally.4 Skilled operative
vaginal birth improves the outcomes forwomen and their babies when birth is
assisted in the second stage of labor for
suspected fetal compromise and/or
delay4,5 compared with cesarean de-
livery. Despite this fact, the rate of ce-
sarean delivery is increasing, whereas the
rate of operative vaginal birth is low or
nonexistent in many health services (re-
ported rates as low as 0.5% of births).6
The reasons for low operative vaginal
birth rates include inexperienced health-
care workers, lack of equipment, and
operator and patient dislike of currently
available methods.6 A new device to assist
vaginal birth provides an opportunity to
improve outcomes and reinvigorate this
essential life-saving skill. However, in
contrast to the huge advances in medical
care over the past 70 years, no new
method for assisting vaginal birth hasMONTH 2020 Ambeen introduced into clinical practice
since the development of the vacuum
extractor in the 1950s. The advantages of
the Odon Device compared with the ad-
vantages of standard methods for assist-
ing birth (ie, forceps and vacuum) are
currently unknown as the device has not
yet been used in clinically indicated cases.
Potential advantages could include
improved neonatal outcomes (eg, reduc-
tion in subaponeurotic and retinal hem-
orrhages, skull fracture, and facial nerve
palsy), increased maternal acceptability,
reduction in failed rate of operative
vaginal birth, decreased risk of adverse
maternal outcomes (eg, postpartum
hemorrhage and vaginal tears), and
ease of use (ie, the same application
technique of the device for all cephalic
positions).erican Journal of Obstetrics & Gynecology 1.e1
AJOG at a Glance
Why was this study conducted?
No new method of operative vaginal birth has been introduced since the devel-
opment of the vacuum extractor in the 1950s. The Odon Device is a new type of
instrument that uses a circumferential air cuff over the fetal head and offers an
alternative to vacuum and forceps.
Key findings
There was no serious maternal or neonatal adverse event related to the use of the
Odon Device. In the first 40 clinically indicated cases ever to be conducted, the
Odon Device was successful in 19 (48%), and there was a high maternal birth
perception score.
What does this add to what is known?
The Odon Device currently has a lower success rate than current devices, but this
should improve with technique refinements. High recruitment rates to studies of
novel devices to assist birth are feasible.
FIGURE 1
The Odon Device component parts
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
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1.e2 American Journal of Obstetrics & Gynecology MONTH 2020The Odon Device is a new device that
can be used for operative vaginal birth
(Figure 1) consisting of a plastic appli-
cator and polyethylene sleeve. The appli-
cator has 4 flexible spatulas that position
the sleeve over the fetal head. A progress
indicator allows the operator to confirm
the correct depth of insertion. The sleeve
contains a circumferential air chamber
that is inflated around the fetal head,
providing the grip for the operator to
apply traction (Video). The instructions
for the use of the Odon Device are shown
in Supplemental Figure 1. A phase 1
study of 4 earlier versions of the
Odon Device in 49 healthy volunteers
(women who were about to have a
spontaneous vaginal birth) demon-
FIGURE 2
Consent and allocation to the intervention criteria
AVB, atrioventricular block.
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
ajog.org OBSTETRICS Original Researchstrated that the device could be
applied to the fetal head during the
second stage of labor with no serious
safety concern.7 Animal studies weresubsequently performed for safety,
and an extensive program of simulation
studies confirmed that the device could
be reliably sited and used in occiputMONTH 2020 Amanterior, occiput transverse, and occiput
posterior fetal positions.8e11
The ASSIST Study used the Odon
Device to assist birth for routine clinicalerican Journal of Obstetrics & Gynecology 1.e3
FIGURE 3
Secondary outcomes
BD, Becton, Dickinson and Company.
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
Original Research OBSTETRICS ajog.orgindications: suspected fetal compromise
and/or failure to progress in the second
stage of labor. The study aimed to
investigate the feasibility of recruitment
and to investigate the efficacy, safety, and
acceptability of the Odon Device to




This is a nonrandomized, single-arm
feasibility study of the Odon Device for
40 women who required an operative
vaginal birth for a recognized clinical
indication. Qualitative work that
explored the experience and views of
women and clinicians will be published
in full, separately.
Population
Potential participants were approached
at Southmead Hospital, Bristol, United
Kingdom. Figure 2 outlines the1.e4 American Journal of Obstetrics & Gynecologyeligibility criteria for initial consent
and allocation to the intervention if an
operative vaginal birth for a clinical
indication was required for prolonged
second stage of labor or presumed fetal
compromise—as defined by the Royal
College of Obstetricians & Gynaecol-
ogists.12 Women were provided with
study information through a verbal
discussion, an information leaflet, and
a video demonstrating the Odon
Device.
Intervention
Odon Deviceeassisted births were con-
ducted by 1 of 5 obstetricians who had
undergone specialized training
(Supplemental Figure 2). If the Odon
Device was unsuccessful, the obstetrician
used their clinical judgment to complete
the birth using forceps, vacuum, or ce-
sarean delivery. After use (following
high-level disinfection), devices were
systematically examined by the studyMONTH 2020team and manufacturer. The device
was used in women who had a fully
dilated cervix, with the vertex presenting
at or below the ischial spines, in any
position.
Outcomes
The primary feasibility outcome was the
proportion of approached and eligible
women agreeing to participate. The
primary clinical outcome was the pro-
portion of births successfully assisted
with the Odon Device. A birth was
defined as “successful” if all of the
following 6 criteria were met: (1) vaginal
birth assisted with the Odon Device, (2)
no serious maternal adverse reaction13
related to the use of the device, (3) no
serious neonatal adverse reaction13
related to the use of the device, (4) no
serious adverse device effect,13 (5)
woman’s perception of her birth of >6
(Patient Perception Score [PPS]14)
(Supplemental Table 1), and (6)
FIGURE 4
The ASSIST Study CONSORT diagram
AVB, atrioventricular block; CONSORT, Consolidated Standards of Reporting Trials; NIPE, Newborn and Infant Physical Examination;
NIPS, Neonatal Infant Pain Score.
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(Supplemental Table 2).
The PPS has been previously vali-
dated for operative vaginal birth.14
Operators were asked their perceptions
of the use of the device using a simple,
nonvalidated tool (Supplemental
Table 2). Secondary outcomes
included metrics related to study feasi-
bility and safety (ie, maternal perineal
trauma and measured blood loss,
neonatal soft tissues trauma and pain,
and device safety) (Figure 3). Neonates
were followed up to day 28 via notes
review and mothers on days 7, 28, and
90 after birth via telephone consulta-
tion. Further details are contained in the
published study protocol.15
Sample size
Sample sizes between 24 and 50 have
been recommended for feasibility
studies.16,17 A complete sample size of
40 women was fixed a priori to enable
the estimation of a potential rate of
successful operative vaginal birth of
80% to within a 95% confidence inter-
val (CI) of 12%. This sample size will
demonstrate the use of a secondary in-
strument of 50% to within a 95% CI of
15%.
Statistical analysis
Data were entered and stored on a
bespoke study database (GeneSYS)
designed and managed by the Clinical
Trial and Evaluation Unit, University
of Bristol, Bristol, United Kingdom.
Data were analyzed using Stata
(version 15.1, StataCorp, College Sta-
tion, TX). Continuous variables were
reported as mean and standard devi-
ation or median and interquartile
range; categorical variables were re-
ported as frequency and percentages.
Relationships among characteristics
that affect the success of the Odon
Device were explored using nonpara-
metric tests, the Fisher exact test for
categorical variables, and the Mann-
Whitney test for continuous variables.
Ethics
This study was approved by South
CentraleBerkshire REC, United
Kingdom, on September 3, 2018 (18/SC/0344), the Medicines and Healthcare
Products Regulatory Agency on August
9, 2018, and the Health Research Au-
thority on September 3, 2018.
Results
Recruitment
Women were recruited between October
2018 and January 2019 (Figure 4).
Pregnancy notes of 545 women were
screened; 441 of 545 women (80.9%)
were initially deemed eligible and
approached. Furthermore, 57 of the
approached women were then identified
to be ineligible. Of the 384 women who
were approached and eligible, 298
(77.6%) consented to participate should
they require an operative vaginal birth
(Figure 4).MONTH 2020 AmOf the 298 women who had
consented, 224 (75.2%) did not have
an operative vaginal birth: 139
(62.1%) had a spontaneous vaginal
birth, 76 (33.9%) had a cesarean
delivery, and 9 (4.0%) were not yet
in labor when the recruitment target
was reached. In addition, 72 women
(24.2%) who had provided consent
required an operative vaginal birth;
the Odon Device was used in 40
cases (55.6%).
Data quality
There were minimal missing data: body
mass index at 36 weeks’ gestation (6 of
40, 15%); umbilical artery pH and base
excess (7 of 40, 18%); umbilical vein pH
and base excess (4 of 40, 10%); Neonatalerican Journal of Obstetrics & Gynecology 1.e5
TABLE 1
Demographics and characteristics of participants
Variable Overall (n¼40)
Maternal age (y) 28.94.8
BMI at booking 25.35.5
BMI at 36 wk 29.45.7a
Ethnicity
White British 32 (80.0)
Any other white background 4 (10.0)
Black African 1 (2.5)
Black Caribbean 1 (2.5)
Indian 1 (2.5)




Previous cesarean delivery 1 (2.5)
Length of gestation (wk) 39.01.3
Birthweight (g) 3198542
3120 (2800e3602)
Head circumference (cm) 34.01.6
Duration of first stage of labor (min) 342199
321 (188e480)
Duration of second stage of labor (min) 11263
103 (67e152)
Induced labor 34 (85.0)
Primary indication for operative vaginal birth
Presumed fetal compromise 29 (72.5)





Fetal head palpable per abdomen
0/5 40 (100.0)
1/5 0 (0.0)
Station of fetal head
Spines 3 (7.5)
þ1 cm below the spines 18 (45.0)
þ2 cm below the spines 18 (45.0)
þ3 cm below the spines 1 (2.5)
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020. (continued)
Original Research OBSTETRICS ajog.orgInfant Pain Score (NIPS)18 at 2 hours
postnatal (1 of 40, 3%); and NIPS at 6
hours postnatal (5 of 40, 13%).1.e6 American Journal of Obstetrics & GynecologyParticipants were deemed lost to follow-
up if they did not respond within 4 days
of the planned follow-up. Follow-up wasMONTH 2020not obtained from 3 (8%) and 4 (10%)
women on day 28 and 90, respectively. A




Table 1 summarizes the demographics
and birth characteristics. Furthermore, 29
women (73%) had an operative vaginal
birth for presumed fetal compromise and
11 women (28%) for prolonged second
stage of labor. Birth was assisted in all
cephalic fetal positions, at all stations at or
below the ischial spines and with or
without regional analgesia.
Primary clinical outcome
The Odon Device was the only device
required to assist birth in 19 of 40 cases
(48%). There was no serious maternal or
neonatal adverse reaction related to the
use of the device during birth, and there
was no serious adverse device effect. All
practitioners found the device easy to
use; however, 1 woman (3%) whose
birth was assisted using the Odon Device
reported her perception of the operative
birth as poor. Therefore, by our a priori
definition, the proportion of births that
were “successfully” assisted with the
Odon Device was 18 of 40 (45%).
Additional assistance was required to
complete the birth in 21 of 40 cases
(52%). Of the 40 cases, 18 (45%) were
completed using nonrotational forceps,
1 (3%) required rotational forceps, and 2
(5%) required an emergency cesarean
delivery (1 immediately following an
unsuccessful Odon Device and 1 after a
failed attempt using rotational forceps).
The fetal vertex was at the level of the
ischial spines in all cases requiring rota-
tional forceps or cesarean delivery.
In addition, 39 of 40 devices (98%)were
inspected after use, and 4 of 40 devices
(10%) had a fault in the bulb pump
mechanism, unable to inflate the air cuff.
None of the faulty device had been suc-
cessful, and in each case, the operator had
raised concerns that the air chamber had
not inflated adequately during use.
Characteristics that affect the
success of the Odon Device
Table 2 summarizes the characteristics of
36 births, which were assisted with
TABLE 1









1 cm 9 (22.5)
2 cm 16 (40.0)
3 cm 4 (10.0)
Analgesia
None 1 (2.5)
Perineal infiltration 12 (30.0)
Pudendal block 1 (2.5)
Regional anesthesia 34 (85.0)




Data are presented as meanstandard deviation, number (percentage) or median (interquartile range).
BMI, body mass index; OA, occiput anterior; OP, occiput posterior; OT, occiput transverse.
a The number of participants is only 34.
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
ajog.org OBSTETRICS Original Researchnonfaulty devices by success (19 cases)
and failure (17 cases). Station (P¼.014)
and degree of molding (P¼.022) were
strongly related to the success of the
device; higher fetal station and/or
increased molding was associated with
lower device success rates. Caput
(P¼.057) may also affect the success of
the device; greater degrees of caput were
associated with a higher likelihood of
failure. There was no evidence to sup-
port any relationship among device
success and onset of labor (P¼.650),
head circumference (P¼.368), primary
indication for operative vaginal birth
(P¼1.000), position of the fetal head
(P¼.843), birthweight (P¼.272), length
of the second stage of labor (P¼.814),
and length of the first stage of labor
(P¼.178).Clinical birth outcomes
Neonatal outcomes
Table 3 summarizes neonatal out-
comes. In this study, 2 infants (1
successful Odon Device and 1 failed
Odon Device followed by nonrota-
tional forceps, both cases assisted for
“presumed fetal compromise”) had an
Apgar score of <7 at 5 minutes of life
(both Apgar scores of 6). No infant
was born with an Apgar score of <7 at
5 minutes where the indication to
assisted birth was prolonged second
stage of labor. In addition, 3 infants
(8%) were admitted to the neonatal
intensive care unit (NICU) following
birth, all with respiratory distress. In all
3 cases, the indication for operative
vaginal birth was “presumed fetal
compromise.” NIPS was reassuring inMONTH 2020 Amonly 1 infant, who was admitted to the
NICU, with a score of 4 indicating
pain.
Most neonatal events (16 of 17) were
attributed to soft tissue trauma (ie,
bruise, graze, scalp injury, or facial
injury) (Table 4). There was less soft
tissue trauma in infants successfully
delivered with the use of the Odon De-
vice; 3 babies (16%) whose birth was
successfully assisted with the Odon De-
vice had evidence of soft tissue trauma
compared with 12 cases (60%) in which
the device failed. In addition, 4 infants
(10%) had a cephalohematoma diag-
nosed at their postnatal checkup (2
successful and 2 unsuccessful cases). No
infant required phototherapy for jaun-
dice contributed to by bruising, received
a blood transfusion, had a neonatal
seizure, was therapeutically cooled, was
diagnosed with organ failure, or died
within 28 days following birth.
Furthermore, 11 infants (28%) expe-
rienced a serious adverse event (SAE)
defined as an event that required hospi-
talization or prolongation of hospital
stay or further intervention: 3 cases of
jaundice requiring phototherapy not
contributed to by bruising; 2 cases of
respiratory difficulties requiring NICU
admission; 1 prolonged neonatal stay for
intravenous antibiotics secondary to
maternal sepsis in labor; 1 hospitaliza-
tion for weight loss; and 1 readmission
for bronchiolitis aged 10 days. None of
the cases were directly attributable to the
use of the Odon Device.
Maternal complications and
clinical features
Table 5 summarizes maternal outcomes.
In this study, 36 of 40 women (90%) had
a perineal tear (28 episiotomies). The
rate of episiotomy in successful Odon
Deviceeassisted births was the same as
when forceps were used—14 of 19 cases
(74%), respectively. Furthermore, 3
women (8%) sustained a third-degree
perineal tear: 1 (3%) during the suc-
cessful use of the Odon Device and 2
(5%) when forceps were used following a
failed Odon attempt. In addition, 1 cer-
vical tear (3%) (which did not requireerican Journal of Obstetrics & Gynecology 1.e7
TABLE 2





Maternal age (y) 28.105.40 29.904.20
BMI at booking 25.225.30 25.305.60
BMI at 36 wk 28.605.40a 29.606.00b
Ethnicity
White British 15 (78.9) 15 (88.2)
Any other white background 3 (15.8) 0 (0.0)
Black African 0 (0.0) 1 (5.9)
Black Caribbean 0 (0.0) 0 (0.0)
Indian 1 (5.3) 0 (0.0)
Any other Asian background 0 (0.0) 1 (5.9)
Parity
0 16 (84.2) 14 (82.3)
1 3 (15.8) 3 (17.6)
Previous cesarean delivery 0 (0.0) 1 (5.9)





Head circumference (cm) 34.001.50 34.001.50








Induced labor 17 (89.5) 14 (82.4)
Primary indication for operative vaginal birth
Presumed fetal compromise 14 (73.7) 13 (76.5)
Delay in the second stage of labor 5 (26.3) 4 (23.5)
Fetal position
OA 14 (73.7) 14 (82.4)
OT 2 (10.5) 2 (11.8)
OP 3 (15.8) 1 (5.9)
Fetal head palpable per abdomen
0/5 19 (100.0) 17 (100.0)
1/5 0 (0.0) 0 (0.0)
Station of fetal head
Spines 0 (0.0) 3 (17.6)
þ1 cm below the spines 6 (31.6) 10 (58.8)
þ2 cm below the spines 12 (63.2) 4 (23.5)
þ3 cm below the spines 1 (5.3) 0 (0.0)
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020. (continued)
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1.e8 American Journal of Obstetrics & Gynecology MONTH 2020suturing) was identified after a successful
Odon Deviceeassisted delivery.
The median weighed blood loss was
499 mL (25th 355 mL, 75th 810 mL).
Furthermore, 2 women (5%) received a
postnatal red blood cell transfusion. In
both cases, the Odon Device had been
unsuccessful, and nonrotational forceps
were used, resulting in hemorrhage from
perineal trauma.
In addition, 7 women (18%) experi-
enced an SAE: 3 third-degree tears, 2
postpartum hemorrhages required
blood transfusion, 1 postnatal infection,
1 complication from a known neuro-
logic condition, and 1 case of fecal in-
continence at 28 days after birth.
Women reported a better health score
(standardized EQ-5D-5L health-related
quality-of-life questionnaire) at day 28
(mean, 88.1; standard deviation [SD],
8.6) compared with antenatally (mean,
82.4; SD, 12.0) and on day 1 postnatal
(mean, 77.1; SD, 16.1).
Device outcomes
In the 19 cases in which the Odon Device
assisted the birth of the baby, the median
time between the application of the de-
vice and time of birth was 5 minutes
(25th 4, 75th 7), with a median “deci-
sion-to-delivery” interval of 11 minutes
(25th 9, 75th 17). There were 21 births
where the Odon Device did not assisted
the birth of the baby: a manufacturing
error affecting 4 devices accounted for
19% of the failed births; 3 failures (14%)
occurred when the vertex was at the level
of the ischial spines; further failures were
attributed to (1) failure to reach “0”
during the application of the device
(n¼6, 29%), (2) operator learning curve
(n¼3, 14%), and (3) no reason identified
(n¼5, 24%).
The operator reported that the device
was “easy” or “very easy” to “set up” and
“deflate the air chamber” in 38 (95%)
and 35 (88%) of 40 cases, respectively.
The application of the device and the
withdrawal of the applicator were more
challenging: only 21 (53%) and 20
(50%) cases were reported as “easy” or
“very easy,” respectively.
The 5 operators joined the study in
stages. The number of births and success
rates per operator were variable
TABLE 2







None 0 (0.0) 0 (0.0)
þ 8 (42.1) 1 (5.9)
þþ 9 (47.4) 13 (76.0)
þþþ 1 (5.3) 3 (17.6)
Caput
None 1 (5.3) 0 (0.0)
1 cm 8 (42.1) 1 (5.9)
2 cm 3 (15.8) 6 (35.3)
3 cm 7 (36.8) 7 (41.2)
Analgesiac
None 1 (5.3) 0 (0.0)
Perineal infiltration 7 (36.8) 2 (11.8)
Pudendal block 0 (0.0) 0 (0.0)
Regional anesthesia 15 (78.9) 15 (88.2)
General anesthesia 0 (0.0) 0 (0.0)
Grade of operator
Attending 14 (73.7) 13 (76.5)
Trainee 5 (26.3) 4 (23.5)
Data are presented as meanstandard deviation, number (percentage) or median (interquartile range).
BMI, body mass index; OA, occiput anterior; OP, occiput posterior; OT, occiput transverse.
a n¼16; b n¼15; c more than 1 type of analgesia can be used.
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
ajog.org OBSTETRICS Original Research(Figure 5). Operator Awas successful in 5
of 15 births (33%), operator B in 7 of 10
births (70%), operator C in 2 of 4 births
(50%), operator D in 3 of 9 births (33%),
and operator E in 2 of 2 births (100%).
Comment
Principal findings
It is feasible to recruit women to a study
investigating a novel device for operative
vaginal birth. A recruitment rate of 78%
is high and appears to be related to a
general maternal aspiration for an
alternative to forceps and vacuum (de-
tails from qualitative findings that will be
published separately). The success rate of
the Odon Device was lower than the
reported success rates of both vacuum
and forceps12,19; however, the device hadbeen used to induce birth where clini-
cally indicated.
Results
Factors that are likely to affect the ef-
ficacy of the device assisted the clinical
context, technique of application and
traction, the initial uncertainty of the
optimal technique in inserting and
using the device (as the device was used
for clinically indicated cases), and the
design and functionality of the device
itself. For example, it became clear af-
ter 3 births that the device is most
effectively placed during a uterine
contraction, in contrast to forceps and
vacuum.
Although the study was not powered
to look at predictors, births were moreMONTH 2020 Amlikely to be successful if the fetal vertex
was lower in the birth canal or if there
wasminimal molding of the fetal skull or
similar other assisted births.12 The Odon
Device was never successful when it was
used with the vertex at the level of the
ischial spines; indeed, a vertex above þ1
is a contraindication to attempting
operative vaginal birth in some national
guidelines.20 The average time of deci-
sion to delivery was 11 minutes, which
was faster than documented average
times in the literature of 15 to 59minutes
depending on whether the birth was
assisted in a labor or operating
room.21e23 The Odon Device was suc-
cessfully employed across the full range
of fetal positions using the same tech-
nique, which may be particularly useful
for maternity settings with low operative
vaginal birth rates. During the routine
device inspection following birth, 4 de-
vices (10%) were found to have a fault
with the inflation mechanism. Further
investigation along with the manufac-
turer identified a single issue related to
the use of gamma radiation in the ster-
ilization process that degraded the device
components. This issue has been recti-
fied by the manufactures and highlights
the importance of postuse device in-
spection during feasibility studies.
Clinical implications
There was no significant maternal or
neonatal safety concern associated with
the use of the device, although the num-
ber of births is small. There seem to be
some neonatal benefits associated with
the use of the device, consistent with the
findings from simulation11; 16%of babies
whose birth was successfully assisted with
the Odon Device had evidence of soft
tissue trauma compared with 60% of ba-
bies in cases where the device was un-
successful. We recorded any soft tissue
trauma, including a bruise, graze, lacera-
tion, or hematoma, whether it appeared
to be related to device use ornot. Evidence
demonstrated that the laceration rate
following operative vaginal delivery can
be up to 10%22 and instrument bruises up
to 37%24; however, there are few studies
reporting all soft tissue injury. We had 4
cephalohematomas (10.3%), whicherican Journal of Obstetrics & Gynecology 1.e9
TABLE 3
Immediate neonatal outcomes
Neonatal outcome Overall (n¼40) Successful Odon (n¼19) Unsuccessful Odon (n¼21)
Umbilical artery pH 7.180.07 7.190.06a 7.180.08b
Umbilical artery base excess 6.6 (8.6 to 5.2) 6.5 (8.5 to 5.7)a 7.0 (9.0 to 4.6)b
Umbilical vein pH 7.33 (7.29 to 7.36) 7.33 (7.30 to 7.36)c 7.31 (7.28 to 7.36)b
Umbilical vein base excess 4.9 (2.3) 4.9 (2.4)c 4.8 (2.3)b
Shoulder dystocia 1 (2.5) 0 (0.0) 1 (4.8)
Apgar scores<7
1 min 5 (12.5) 3 (15.8) 2 (9.5)
5 min 2 (5.0) 1 (5.3) 1 (4.8)
10 min 0 (0.0) 0 (0.0) 0 (0.0)
Neonatal Infant Pain Scores4
2 h postnatalb 1 (2.6)d 1 (5.6)e 0 (0.0)
6 h postnatalc 0 (0.0) 0 (0.0) 0 (0.0)
Data are presented as meanstandard deviation, number (percentage) or median (interquartile range).
a n¼14; b n¼19; c n¼17; d n¼39; e n¼18.
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Original Research OBSTETRICS ajog.orgagrees published rates of occurrence
following operative vaginal birth.22
Clearly, the use of 2 instruments is asso-
ciated with an increased risk of neonatal
trauma,25 but the trauma rates in this
studywere consistentwith other operative
vaginal birth studies in the same unit.26
Operators used their clinical judgment
to decide whether to use a second device
or perform a cesarean delivery following
the failure of a primary device. This studyTABLE 4
Neonatal outcomes up to day 28
Variable
Admitted to the NICU at any point up to day 28
Neonatal events diagnosed or still present
between NIPE and day 28
Any neonatal event
Neonatal soft tissue trauma





NICU, Neonatal intensive care unit; NIPE, newborn and infant ph
Hotton et al. Novel Odon Device and operative vaginal birt
1.e10 American Journal of Obstetrics & Gynecoloroutinely used NIPS to assess infants
following operative vaginal birth, and the
scores have indicated reassuringly low
levels of neonatal pain.
Maternal outcomes were also accept-
able. No woman required a blood
transfusion after a successful Odon
Deviceeassisted birth compared with
10% of women in unsuccessful cases.
Clearly, this may reflect the use of 2 in-
struments25 and/or a more difficultOverall (n¼40) Successful Odon
3 (7.5) 2 (10.5)
17 (43.6) 4 (21.1)
15 (38.5) 3 (15.8)
0 (0.0) 0 (0.0)
4 (10.3) 2 (10.5)
0 (0.0) 0 (0.0)
0 (0.0) 0 (0.0)
1 (2.6) 1 (5.3)
ysical examination.
h. Am J Obstet Gynecol 2020.
gy MONTH 2020cohort of births. Overall, the maternal
outcomes were again comparable to a
previous study of operative vaginal birth
in the study unit.26 There were 3 third-
degree tears (7.5%) during the study, 1
(5.3%) from a birth successfully assisted
by the Odon Device and 2 (9.5%) from
births requiring a second device to assist
birth. This agrees tear rates in the liter-
ature, which range from 1% to 4% for











Variable Overall (n¼40) Successful Odon (n¼19) Unsuccessful Odon (n¼21)
Weighed blood loss (mL) 499 (355e810) 514 (420e746) 450 (300e1302)
Perineal tears
None 4 (10.0) 1 (5.3) 3 (14.3)
First degree 3 (7.5) 1 (5.3) 2 (9.5)
Second degree 7 (17.5) 2 (10.5) 5 (23.8)
Episiotomy 28 (70.0) 14 (73.7) 14 (66.7)
3A 1 (2.5) 0 (0.0) 1 (4.8)
3B 2 (5.0) 1 (5.3) 1 (4.8)
3C 0 (0.0) 0 (0.0) 0 (0.0)
Fourth degree 0 (0.0) 0 (0.0) 0 (0.0)
Defect in the ischiorectal fossa 2 (5.0) 1 (5.3) 1 (4.8)
Cervical tear present 1 (2.5) 1 (5.3) 0 (0.0)
Cervical tear requiring suturing 0 (0.0) 0 (0.0) 0 (0.0)
Labial tear requiring suturing 1 (2.5) 1 (5.3) 0 (0.0)
Postnatal perception of pain
Day 1 4 (3.0e6.0) 4 (3.0e6.0) 4 (3.0e6.0)
Day 7 3 (1.5e4.0) 3 (1.0e5.0) 3 (2.0e4.0)
Day 28 1 (1.0e2.0) 1 (1.0e1.0) 1 (1.0e2.0)
Symptoms of fecal or flatal incontinence at day 90
Never 0 (0.0)a 0 (0.0)b 0 (0.0)b
Rarely 32 (88.9)a 16 (88.9)b 16 (88.9)b
Sometimes 1 (2.8)a 0 (0.0)b 1 (5.6)b
Often 3 (8.3)a 2 (11.1)b 1 (5.6)b
Always 0 (0.0)a 0 (0.0)b 0 (0.0)b
Symptoms of urinary incontinence at day 90 13 (36.0)a 5 (27.8)b 8 (44.4)b
Data are presented as number (percentage) or median (interquartile range).
a n¼36; b n¼18.
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for women who had births assisted with
sequential devices.25,27
This study routinely collected
maternal birth perceptions as part of
the assessment of operative vaginal
birth. It is encouraging that 98% of
women in the study rated their birth
very positively.
Research implications
A future randomized controlled trial will
be required to objectively compare out-
comes among the Odon Device, forceps,
and vacuum. However, this wouldrequire equipoise among the options for
operative vaginal birth. We are confident
that the success rates of the Odon Device
can be improved with iterative im-
provements to the insertion technique,
refinement of participant selection, and
a more reliable device design. Further
feasibility studies are currently underway




4), and Besançon, France, and the suc-
cess rate has markedly improved in
this second phase; an interim analysis ofMONTH 2020 Amethe current ongoing studies demon-
strated a success rate of 78% (66 of 85
cases).28
Strengths and limitations
The Odon Device has been used in
clinically indicated cases for operative
vaginal birth. It demonstrates an inno-
vative approach to information sharing
and recruitment, with positive results.
The study ensured a holistic approach
when evaluating a novel device, ensuring
that data from women, infants, clini-
cians, midwives, and the device were
scrutinized. Key quantitative data wererican Journal of Obstetrics & Gynecology 1.e11
FIGURE 5
Details of device failure and success by category and operator
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
Original Research OBSTETRICS ajog.orgconsolidated with embedded qualitative
research to enable further understand-
ing. Key limitations included the small
sample size and the reasonably short
follow-up period of 90 days. We inten-
ded to perform long-term follow-up of
women and their babies during the next
phase of the study, following the
completion of our feasibility research.
We acknowledge that this research was1.e12 American Journal of Obstetrics & Gynecoloundertaken in a single center in a single
country where most participants were
white.
Conclusions
Investigating a new device for operative
vaginal birth is both feasible and sup-
ported by women. The potential advan-
tages of the Odon Device (eg, possible
reduction in neonatal soft tissue trauma,gy MONTH 2020single mode of application irrespective
of fetal position) merit further iterative
exploration and investigation of the de-
vice in larger studies.
Highlights
 The Odon Device may offer women
an alternative instrumental birth.
 There was no maternal or neonatal
safety concerns in the births.
 Recruitment rate was higher than
expected. n
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SUPPLEMENTAL FIGURE 1
Instructions for use for the ASSIST Study
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020. (continued)
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SUPPLEMENTAL FIGURE 1
(Continued )
A and B, Device use steps (for clinical investigation only).
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SUPPLEMENTAL FIGURE 2
Operator training for the ASSIST Study
All operators undertaking operative vaginal births as part of the ASSIST Study attended a half-day 
training session. This included an instructional video on the use of the Odon Device, with 
accompanying training slides and intensive 1:1 practical teaching of how to use the Odon Device on a 
high-fidelity pelvic simulator. The training is based on the Royal College of Obstetricians & 
Gynaecologists training course for instrumental birth, ROBuST, and the findings of the extensive 
human factor studies conducted using the Odon Device. The half-day training sessions will be 
repeated if any applicable amendments are made to the study protocol or device, to ensure that all 
operators remain up to date. Should any operator be found during interim analyses to be performing 
with a success rate deemed to be insufficient, they will undergo retraining in both the Odon Device 
training package and ROBuST.
ROBuST, RCOG Operative Birth Simulation Training.
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SUPPLEMENTAL TABLE 1
Patient Perception Score
Women’s perception of birth
Question Strongly disagree Disagree Neutral Agree Strongly agree Score
I felt well informed due to good communication 1 2 3 4 5
I felt I was treated with respect at all times 1 2 3 4 5
I felt safe at all times 1 2 3 4 5
Total
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
Original Research OBSTETRICS ajog.org




Perceived overall ease of use of device Very difficult Very easy
1 2 3 4 5
Ease of instrument setup Very difficult Very easy
1 2 3 4 5
Ease of instrument application to the baby’s head Very difficult Very easy
1 2 3 4 5
Ease of withdrawal of applicator after application Very difficult Very easy
1 2 3 4 5
Comfort with the level of force required to deliver the
baby
Very difficult Veryeasy
1 2 3 4 5
Ease of deflation of the air chamber prior to crowning Very difficult Very easy
1 2 3 4 5
Any other comments or impressions regarding the
delivery with the Odon Device?
Please insert free comments below:
Hotton et al. Novel Odon Device and operative vaginal birth. Am J Obstet Gynecol 2020.
ajog.org OBSTETRICS Original Research
MONTH 2020 American Journal of Obstetrics & Gynecology 1.e17
